John Skehel

John Skehel's AcademicInfluence.com Rankings

John Skehel

Biology

#1338

World Rank

#2264

Historical Rank

Virology

#34

World Rank

#36

Historical Rank

biology Degrees

Download Badge

Biology

Why Is John Skehel Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Sir John James Skehel, is a British virologist and Emeritus scientist at the Francis Crick Institute in London. From 1987 to 2006 he was director of the National Institute of Medical Research at Mill Hill which was incorporated into the Crick Institute in 2016.

(See a Problem?)

John Skehel's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. (2000) (2649)
Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution (1981) (2289)
Atomic structure of the ectodomain from HIV-1 gp41 (1997) (1657)
Structure of influenza haemagglutinin at the pH of membrane fusion (1994) (1537)
Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation (1981) (1501)
The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. (1987) (1355)
A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins (2011) (1086)
Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid (1988) (1082)
Printed covalent glycan array for ligand profiling of diverse glycan binding proteins. (2004) (1019)
The molecular basis of the specific anti‐influenza action of amantadine. (1985) (778)
The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design (2006) (750)
Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion. (1982) (688)
The Structure and Receptor Binding Properties of the 1918 Influenza Hemagglutinin (2004) (663)
Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity (1983) (659)
Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors (2006) (617)
Structure of an unliganded simian immunodeficiency virus gp120 core (2005) (568)
Influenza Hemagglutinin and Neuraminidase Membrane Glycoproteins* (2010) (531)
Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion (2020) (521)
Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants (2008) (502)
Structure of the Hemagglutinin Precursor Cleavage Site, a Determinant of Influenza Pathogenicity and the Origin of the Labile Conformation (1998) (497)
A carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody. (1984) (444)
X-ray structures of H5 avian and H9 swine influenza virus hemagglutinins bound to avian and human receptor analogs (2001) (428)
Coiled Coils in Both Intracellular Vesicle and Viral Membrane Fusion (1998) (408)
SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects (2020) (404)
Crystal structure of the Ebola virus membrane fusion subunit, GP2, from the envelope glycoprotein ectodomain. (1998) (397)
Structural basis for membrane fusion by enveloped viruses. (1999) (355)
Crystalline antigen from the influenza virus envelope. (1972) (329)
Hemagglutinins from two influenza virus variants bind to sialic acid derivatives with millimolar dissociation constants: a 500-MHz proton nuclear magnetic resonance study. (1989) (315)
Binding of influenza virus hemagglutinin to analogs of its cell-surface receptor, sialic acid: analysis by proton nuclear magnetic resonance spectroscopy and X-ray crystallography. (1994) (305)
Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion (2008) (296)
Receptor binding by an H7N9 influenza virus from humans (2013) (290)
Cloning and DNA sequence of double-stranded copies of haemagglutinin genes from H2 and H3 strains elucidates antigenic shift and drift in human influenza virus (1980) (287)
Interferon action—sequence specificity of the ppp(A2′p)nA-dependent ribonuclease (1981) (283)
N- and C-terminal residues combine in the fusion-pH influenza hemagglutinin HA(2) subunit to form an N cap that terminates the triple-stranded coiled coil. (1999) (280)
Structure and Function Analysis of an Antibody Recognizing All Influenza A Subtypes (2016) (275)
Single-particle kinetics of influenza virus membrane fusion (2008) (250)
Studies on the primary structure of the influenza virus hemagglutinin. (1975) (249)
Transcription of the influenza virus genome. (1977) (248)
Evolution of the receptor binding properties of the influenza A(H3N2) hemagglutinin (2012) (243)
Structure of influenza virus haemagglutinin complexed with a neutralizing antibody (1995) (241)
The polypeptide composition of influenza A viruses. (1971) (234)
H5 avian and H9 swine influenza virus haemagglutinin structures: possible origin of influenza subtypes (2002) (230)
Studies on the in vitro transcription of reovirus RNA catalyzed by reovirus cores. (1969) (225)
Structure of the haemagglutinin-esterase-fusion glycoprotein of influenza C virus (1998) (220)
Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion (2001) (217)
Membrane fusion by peptide analogues of influenza virus haemagglutinin. (1988) (210)
Binding of the influenza A virus to cell-surface receptors: structures of five hemagglutinin-sialyloligosaccharide complexes determined by X-ray crystallography. (1997) (209)
Refinement of the influenza virus hemagglutinin by simulated annealing. (1991) (198)
H1 and H7 influenza haemagglutinin structures extend a structural classification of haemagglutinin subtypes. (2004) (194)
Polypeptide synthesis in influenza virus-infected cells. (1972) (192)
Molecular basis of resistance of influenza A viruses to amantadine. (1986) (190)
Receptor binding by a ferret-transmissible H5 avian influenza virus (2013) (189)
The influenza A virus nucleoprotein gene controls the induction of both subtype specific and cross-reactive cytotoxic T cells (1984) (186)
The receptor‐binding and membrane‐fusion properties of influenza virus variants selected using anti‐haemagglutinin monoclonal antibodies. (1987) (185)
Structures of receptor complexes formed by hemagglutinins from the Asian Influenza pandemic of 1957 (2009) (176)
Studies of the membrane fusion activities of fusion peptide mutants of influenza virus hemagglutinin (1995) (176)
Introduction of intersubunit disulfide bonds in the membrane-distal region of the influenza hemagglutinin abolishes membrane fusion activity (1992) (172)
Nucleotide sequences at the 5' termini of influenza virus RNAs and their transcripts. (1978) (171)
A complex of influenza hemagglutinin with a neutralizing antibody that binds outside the virus receptor binding site (1999) (164)
Studies on the structure of the influenza virus haemagglutinin at the pH of membrane fusion. (1988) (159)
Studies with crosslinking reagents on the oligomeric structure of the env glycoprotein of HIV. (1989) (159)
A soluble domain of the membrane-anchoring chain of influenza virus hemagglutinin (HA2) folds in Escherichia coli into the low-pH-induced conformation. (1995) (153)
Conformational changes in the hemagglutinin of influenza virus which accompany heat-induced fusion of virus with liposomes. (1986) (151)
X-ray structure of the hemagglutinin of a potential H3 avian progenitor of the 1968 Hong Kong pandemic influenza virus. (2003) (149)
An antibody that prevents the hemagglutinin low pH fusogenic transition. (2002) (148)
Analyses of the antigenicity of influenza haemagglutinin at the pH optimum for virus-mediated membrane fusion. (1983) (147)
Mechanism of neutralization of influenza virus infectivity by antibodies. (2002) (146)
Cytotoxic T cells to type A influenza virus; viral hemagglutinin induces A‐strain specificity while infected cells confer cross‐reactive cytotoxicity (1977) (146)
Studies of the binding properties of influenza hemagglutinin receptor-site mutants. (1998) (141)
Variation and infectivity neutralization in influenza (2006) (138)
The ectodomain of HIV‐1 env subunit gp41 forms a soluble, alpha‐helical, rod‐like oligomer in the absence of gp120 and the N‐terminal fusion peptide. (1996) (136)
The polypeptides of adenovirus-infected cells. (1972) (131)
Electron microscopy of the low pH structure of influenza virus haemagglutinin. (1986) (131)
Selection of gp41-mediated HIV-1 cell entry inhibitors from biased combinatorial libraries of non-natural binding elements (1999) (131)
On the mechanism of inhibition of influenza virus replication by amantadine hydrochloride. (1978) (131)
Electron microscopy of antibody complexes of influenza virus haemagglutinin in the fusion pH conformation. (1995) (129)
Antigen distortion allows influenza virus to escape neutralization (1998) (127)
Composition and functions of the influenza fusion peptide. (2009) (125)
The central structural feature of the membrane fusion protein subunit from the Ebola virus glycoprotein is a long triple-stranded coiled coil. (1998) (124)
Influenza A Viruses with Mutations in the M1 Helix Six Domain Display a Wide Variety of Morphological Phenotypes (2005) (123)
Analysis of residues near the fusion peptide in the influenza hemagglutinin structure for roles in triggering membrane fusion. (2008) (122)
rRNA cleavage as an index of ppp(A2'p)nA activity in interferon-treated encephalomyocarditis virus-infected cells (1983) (122)
Studies of influenza haemagglutinin-mediated membrane fusion. (1986) (120)
Amantadine selection of a mutant influenza virus containing an acid-stable hemagglutinin glycoprotein: evidence for virus-specific regulation of the pH of glycoprotein transport vesicles. (1991) (120)
Three-dimensional structure of an antigenic mutant of the influenza virus haemagglutinin (1984) (120)
Avian and human receptor binding by hemagglutinins of influenza A viruses (2006) (119)
Antigenic similarity of influenza A (H1N1) viruses from epidemics in 1977--1978 to "Scandinavian" strains isolated in epidemics of 1950--1951. (1978) (117)
Genetics of influenza viruses. (2002) (117)
Structural basis for oseltamivir resistance of influenza viruses. (2009) (115)
Host-mediated selection of influenza virus receptor variants. Sialic acid-alpha 2,6Gal-specific clones of A/duck/Ukraine/1/63 revert to sialic acid-alpha 2,3Gal-specific wild type in ovo. (1985) (115)
Characterization of influenza virus RNA complete transcripts. (1982) (114)
A surface plasmon resonance assay for the binding of influenza virus hemagglutinin to its sialic acid receptor. (1996) (113)
Electron microscopy of the human respiratory syncytial virus fusion protein and complexes that it forms with monoclonal antibodies. (2000) (110)
Sequential mutations in hemagglutinins of influenza B virus isolates: definition of antigenic domains. (1983) (107)
Crystal structures of influenza virus hemagglutinin in complex with high-affinity receptor analogs. (1994) (106)
Structure of the haemagglutinin of influenza virus. (1979) (106)
Evidence from studies with a cross-linking reagent that the haemagglutinin of influenza virus is a trimer. (1977) (105)
The effect of the D614G substitution on the structure of the spike glycoprotein of SARS-CoV-2 (2021) (103)
Comparative analyses of the specificities of anti-influenza hemagglutinin antibodies in human sera (1986) (97)
Studies on the adaptation of influenza viruses to MDCK cells. (1984) (93)
Role of virion M2 protein in influenza virus uncoating: specific reduction in the rate of membrane fusion between virus and liposomes by amantadine. (1994) (92)
Ligand recognition by influenza virus. The binding of bivalent sialosides. (1991) (89)
Virus Replication in Enucleate Cells: Vesicular Stomatitis Virus and Influenza Virus (1974) (89)
Studies on influenza haemagglutinin fusion peptide mutants generated by reverse genetics (2001) (89)
The preparation and properties of adenovirus cores. (1971) (88)
Adaptation of egg-grown and transfectant influenza viruses for growth in mammalian cells: selection of hemagglutinin mutants with elevated pH of membrane fusion. (1997) (88)
The structure of the influenza virus haemagglutinin glycoprotein at 3 Ã resolution (1981) (85)
Structural evidence for recognition of a single epitope by two distinct antibodies (2000) (80)
The size and shape of influenza virus neuraminidase. (1973) (80)
Influenza A specific cytotoxic T-cell clones that do not recognize viral glycoproteins (1982) (77)
H1N1 2009 Pandemic Influenza Virus: Resistance of the I223R Neuraminidase Mutant Explained by Kinetic and Structural Analysis (2012) (76)
Crystallographic detection of a second ligand binding site in influenza virus hemagglutinin. (1992) (74)
Effect of proteolytic processing at two distinct sites on shape and aggregation of an anchorless fusion protein of human respiratory syncytial virus and fate of the intervening segment. (2002) (70)
Receptor binding by H10 influenza viruses (2014) (70)
Determining the structure of an unliganded and fully glycosylated SIV gp120 envelope glycoprotein. (2005) (70)
Studies using double mutants of the conformational transitions in influenza hemagglutinin required for its membrane fusion activity. (1996) (70)
Assembly of a rod-shaped chimera of a trimeric GCN4 zipper and the HIV-1 gp41 ectodomain expressed in Escherichia coli. (1997) (69)
A Human Antibody Recognizing a Conserved Epitope of H5 Hemagglutinin Broadly Neutralizes Highly Pathogenic Avian Influenza H5N1 Viruses (2012) (68)
The structure of a membrane fusion mutant of the influenza virus haemagglutinin. (1990) (68)
Plasticity of influenza haemagglutinin fusion peptides and their interaction with lipid bilayers. (2005) (68)
Evolution in the Microbial World (1975) (68)
The immune response of BALB/c mice to influenza hemagglutinin: commonality of the B cell and T cell repertoires and their relevance to antigenic drift (1989) (67)
Purification of virus glycoproteins by affinity chromatography using Lens culinaris phytohaemagglutinin (1973) (66)
The matrix protein gene determines amantadine-sensitivity of influenza viruses. (1979) (66)
Deacylation of the hemagglutinin of influenza A/Aichi/2/68 has no effect on membrane fusion properties. (1991) (65)
Ground penetrating radar surveys to locate 1918 Spanish flu victims in permafrost. (2000) (64)
Analysis of antigenic variation in equine 2 influenza A viruses. (1983) (62)
Membrane fusion by influenza hemagglutinin. (1995) (61)
RNA-dependent RNA polymerase activity of the influenza virus. (1971) (59)
Amino acid sequences of haemagglutinins of influenza viruses of the H3 subtype isolated from horses. (1985) (57)
Receptor-binding characteristics of monoclonal antibody-selected antigenic variants of influenza virus (1987) (57)
Structural transitions in influenza haemagglutinin at membrane fusion pH (2020) (57)
Influenza virus messenger RNAs are incomplete transcripts of the genome RNAs. (1977) (56)
Structure and binding properties of Pangolin-CoV spike glycoprotein inform the evolution of SARS-CoV-2 (2020) (56)
Antigenic analyses of influenza virus haemagglutinins with different receptor-binding specificities. (1984) (56)
Electron microscopic evidence for the axial rotation and inter-domain flexibility of the Fab regions of immunoglobulin G. (1983) (55)
The origin of pandemic influenza viruses. (1974) (54)
The polypeptide composition of mouse mammary tumor virus. (1974) (54)
Proteins synthesized in chick cells following infection with Semliki Forest virus. (1968) (52)
Electron microscopy of influenza haemagglutinin-monoclonal antibody complexes. (1983) (48)
Temperature dependence of fusion by sendai virus. (2000) (48)
Extensive diversity in the recognition of influenza virus hemagglutinin by murine T helper clones (1986) (47)
Recognition of influenza A virus nucleoprotein by an H-2-restricted cytotoxic T-cell clone. (1984) (47)
Recent evolution of equine influenza and the origin of canine influenza (2014) (47)
An overview of influenza haemagglutinin and neuraminidase. (2009) (47)
Effects of actinomycin D and 2-mercapto-1-(β-4-pyridethyl) benzimidazole on the incorporation of [3H]uridine by chick embryo cells (1967) (46)
I-Ad restricted T cell recognition of influenza hemagglutinin. Synthetic peptides identify multiple epitopes corresponding to antibody-binding regions of the HA1 subunit. (1989) (46)
Crystallization and x-ray diffraction studies on the haemagglutinin glycoprotein from the membrane of influenza virus. (1977) (45)
The structure of an HIV-1 specific cell entry inhibitor in complex with the HIV-1 gp41 trimeric core. (2000) (45)
The structural requirements for class II (I‐Ad)‐restricted T cell recognition of influenza hemagglutinin: B cell epitopes define T cell epitopes (1989) (45)
Conformational‐dependent recognition of influenza virus hemagglutinin by murine T helper clones (1986) (45)
Potent adaptive immune responses induced against HIV-1 gp140 and influenza virus HA by a polyanionic carbomer. (2010) (45)
Conformational aspects of the acid-induced fusion mechanism of influenza virus hemagglutinin. Circular dichroism and fluorescence studies. (1988) (45)
Gamblin Hemagglutinin The Structure and Receptor Binding Properties of the 1918 Influenza (2012) (44)
Structures of complexes formed by H5 influenza hemagglutinin with a potent broadly neutralizing human monoclonal antibody (2015) (44)
Nucleotide sequences at the terminal of La Crosse virus RNAs. (1980) (43)
Crystals of a fragment of influenza haemagglutinin in the low pH induced conformation. (1994) (43)
Structure, Function, and Antigenicity of the Hemagglutinin of Influenza Virus (1989) (42)
Estimations of the molecular weight of the influenza virus genome. (1971) (42)
Procedures for characterisation of the genetic material of candidate vaccine strains. (1977) (40)
The characterization of subviral particles derived from influenza virus. (1971) (40)
Thermostability of the human respiratory syncytial virus fusion protein before and after activation: implications for the membrane-fusion mechanism. (2004) (40)
Amantadine blocks the channel (1992) (39)
Antibody-mediated disruption of the SARS-CoV-2 spike glycoprotein (2020) (38)
Interferon production and RNA inhibitors. (1967) (37)
Expression, Purification, and Characterization of gp160e, the Soluble, Trimeric Ectodomain of the Simian Immunodeficiency Virus Envelope Glycoprotein, gp160* (2000) (37)
In vitro synthesis, glycosylation, and membrane insertion of influenza virus haemagglutinin. (1979) (36)
Proton nuclear magnetic resonance studies of the binding of sialosides to intact influenza virus. (1992) (35)
Full-length influenza hemagglutinin HA2 refolds into the trimeric low-pH-induced conformation. (2004) (35)
Ribonucleic Acid Synthesis in Chick Embryo Cells Infected with Fowl-Plague Virus (1969) (34)
Early polypeptide synthesis in influenza virus-infected cells. (1973) (33)
Changes in the hemagglutinin of H5N1 viruses during human infection – Influence on receptor binding☆ (2013) (32)
Characterization of temperature-sensitive mutants of adenovirus type 5: synthesis of polypeptides in infected cells. (1974) (32)
Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion (2020) (32)
A Novel I221L Substitution in Neuraminidase Confers High-Level Resistance to Oseltamivir in Influenza B Viruses (2014) (31)
Spontaneous and tryptic degradation of virus particles and structural components of adenoviruses. (1971) (30)
Characterization of virus-specific messenger RNAs from avian fibroblasts infected with fowl plague virus. (1977) (30)
Epitope mapping of cross-reactive monoclonal antibodies specific for the influenza A virus PA and PB2 polypeptides. (1995) (30)
Experimental influenza causes a non-permissive viral infection of brain, liver and muscle. (2000) (29)
Recognition of sulphated and fucosylated receptor sialosides by A/Vietnam/1194/2004 (H5N1) influenza virus. (2013) (29)
Diversity of the class II (I-Ak/I-Ek)-restricted T cell repertoire for influenza hemagglutinin and antigenic drift. Six nonoverlapping epitopes on the HA1 subunit are defined by synthetic peptides (1989) (28)
A polar octapeptide fused to the N-terminal fusion peptide solubilizes the influenza virus HA2 subunit ectodomain. (1998) (28)
Antigenic and amino acid sequence variations in the haemagglutinins of type A influenza viruses recently isolated from human subjects. (1983) (27)
The structure and role of the carbohydrate moieties of influenza virus haemagglutinin. (1983) (27)
Refined three-dimensional structure of the Fab fragment of a murine IgGl,lambda antibody. (1994) (26)
Influenza virus transcription. (1978) (26)
Evolution of the SARS-CoV-2 spike protein in the human host (2021) (24)
Influenza virus haemagglutinin signal sequence (1979) (24)
Enhanced human receptor binding by H5 haemagglutinins (2014) (23)
Infectivity Studies of Influenza Virus Hemagglutinin Receptor Binding Site Mutants in Mice (2008) (23)
Fine specificity of murine class II-restricted T cell clones for synthetic peptides of influenza virus hemagglutinin. Heterogeneity of antigen interaction with the T cell and the Ia molecule. (1988) (22)
Antigenic and amino acid sequence analyses of influenza viruses of the H1N1 subtype isolated between 1982 and 1984. (1985) (22)
H 1 N 1 2009 Pandemic Influenza Virus : Resistance of the I 223 R Neuraminidase Mutant Explained by Kinetic and Structural Analysis (2012) (22)
Structure and synthesis of influenza virus complementary RNAs. (1980) (21)
Disulphide bonds of haemagglutinin of Asian influenza virus (1981) (21)
Influenza viruses and cell membranes. (1995) (20)
Influenza virus transcription. (1978) (20)
Differentiation of the haemagglutinin genes of variant influenza viruses by RNA-RNA hybridization. (1979) (20)
Sequence elements of the fusion peptide of human respiratory syncytial virus fusion protein required for activity. (2006) (20)
The conformation of influenza virus haemagglutinin (1977) (19)
Interferon production by Semliki Forest virus inactivated with hydroxylamine. (1968) (18)
Ligand Recognition by Influenza Virus (1991) (18)
The effect of environmental conditions in vivo and in vitro on the determinants of microbial pathogenicity. (1980) (17)
A temperature-sensitive event in interferon production. (1968) (17)
Expression Cloning and Production of Human Heavy-Chain-Only Antibodies from Murine Transgenic Plasma Cells (2016) (17)
Recovery of an Antiviral Antibody Response following Attrition Caused by Unrelated Infection (2014) (16)
Essential role of MALT 1 protease activity in activated B cell-like diffuse large B-cell lymphoma (2013) (16)
Author Correction: SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects (2020) (16)
Influenza glycoproteins: Hemagglutinin and neuraminidase (2013) (16)
Hemagglutinin Structure and Activities. (2020) (15)
Membrane fusion by surrogate receptor-bound influenza haemagglutinin. (1999) (15)
Interferon production and viral ribonucleic acid synthesis in chick embryo cells. (1967) (15)
A Chimeric Protein of Simian Immunodeficiency Virus Envelope Glycoprotein gp140 and Escherichia coli Aspartate Transcarbamoylase (2004) (15)
The Amino Acid and Carbohydrate Composition of the Neuraminidase of B/Lee/40 Influenza Virus (1977) (15)
Antigenic and amino acid sequence analysis of the variants of H1N1 influenza virus in 1986. (1987) (14)
Structural studies on viral escape from antibody neutralization. (2001) (14)
Crystallization and preliminary X‐ray diffraction studies of complexes between an influenza hemagglutinin and fab fragments of two different monoclonal antibodies (1995) (14)
X‐ray crystallographic determination of the structure of the influenza C virus haemagglutinin‐esterase‐fusion glycoprotein (1999) (14)
1 – Membrane Fusion by Influenza Viruses and the Mechanism of Action of Amantadine (1990) (14)
Influenza virus. Amantadine blocks the channel. (1992) (13)
A single amino acid substitution in influenza hemagglutinin abrogates recognition by monoclonal antibody and a spectrum of subtype‐specific L3T4+ T cell clones (1987) (13)
Hemagglutinin Traits Determine Transmission of Avian A/H10N7 Influenza Virus between Mammals. (2020) (12)
The immunotargeting approach to adjuvant-independent immunization with influenza haemagglutinin. (1993) (12)
Characterization of influenza virus RNA transcripts synthesized in vitro. (1979) (11)
A neutralizing antibody Fab-influenza haemagglutinin complex with an unprecedented 2:1 stoichiometry: characterization and crystallization. (2000) (11)
Genetic composition and virulence of influenza virus: differences in facets of virulence in ferrets between two pairs of recombinants with RNA segments of the same parental origin. (1982) (11)
Characterization of avian influenza viruses isolated in Israel in 1978-1979. (1980) (11)
The molecular basis of microbial pathogenicity: report of the Dahlem Workshop, Berlin, 22-26 October 1979. (1980) (11)
The polypeptides of adenovirus type 12. (1973) (11)
The refinement of the haemagglutinin membrane glycoprotein of influenza virus (1986) (10)
Immunology: Are peptides good antigens? (1985) (10)
Analysis of murine antibody responses to baculovirus-expressed human immunodeficiency virus type 1 envelope glycoproteins. (1994) (10)
Suicide selection of murine T helper clones specific for variable regions of the influenza hemagglutinin molecule (1986) (10)
Antigenic characterization of influenza A (H1N1) viruses recently isolated from pigs and turkeys in France. (1985) (9)
The Transcription of the Reovirus Genome (1970) (9)
Crystallization and preliminary X-ray diffraction studies of a monoclonal antibody Fab fragment specific for an influenza virus haemagglutinin and of an escape mutant of that haemagglutinin. (1990) (8)
B- and T-cell recognition of influenza hemagglutinin. (1989) (8)
Structural changes in influenza virus haemagglutinin at the pH of membrane fusion. (1986) (8)
GM Plants: Questions and Answers (2016) (8)
High level expression of soluble glycoproteins in the allantoic fluid of embryonated chicken eggs using a Sendai virus minigenome system (2007) (8)
Infection of tumour cells by fowl plague virus in the presence of actinomycin D. (1971) (7)
Structural Studies of the Hemagglutinin of the Asian Influenza Virus Japan/305/57 — Bellamy/42 (H2N1).Cyanogen Bromide Cleavage of the Larger Polypeptide Chain HA1 (1978) (7)
Studies on the structure of the haemagglutinin. (1980) (7)
Interferons and other cell products influencing viral multiplication. (1967) (6)
The Influenza Virus Mechanical Properties Are Dominated By Its Lipid Envelope (2009) (6)
11 Receptor Binding and Membrane Fusion by Influenza Hemagglutinin (1994) (6)
The mechanism of neutralization of influenza virus infectivity by antibodies (2002) (5)
Human former seasonal Influenza A(H1N1) haemagglutination inhibition data 1977-2009 from the WHO Collaborating Centre for Reference and Research on Influenza, London, UK (2016) (5)
Antigenic and genetic characterization of current influenza strains (1994) (5)
Preliminary Studies of the Membrane-Associated Portion of the Hemagglutinin (1978) (5)
Virus nucleic acid and interferon formation. (1967) (4)
Evasion of host defenses: group report. (1980) (4)
Are peptides good antigens? (1985) (4)
Structure of Influenza Virus (1974) (4)
A Novel I 221 L Substitution in Neuraminidase Confers High-Level Resistance to Oseltamivir in In fl uenza B Viruses (2014) (4)
Protein components of fowl-plague virus. (1968) (4)
Evolution of SARS-CoV-2 spike glycoprotein (2020) (4)
Ribonucleic acid synthesis in fowl-plague virus-infected chick-embryo cells. (1968) (3)
[Epizootic swine influenza on animal farms in Brittany]. (1983) (3)
On the Activation of Membrane Fusion by Influenza Haemagglutinin (2008) (3)
INFLUENZA ACTIVITY - UNITED-STATES AND WORLDWIDE - COMPOSITION OF THE 1992-1993 INFLUENZA VACCINE (REPRINTED FROM MMWR, VOL 41, PG 315-323, 1992) (1992) (3)
Studies with monoclonal antibodies prepared against X-31 influenza virus haemagglutinin. (1985) (3)
Use of molecular replacement in the solution of an immunoglobulin Fab fragment structure. (1991) (3)
Influenza virus infection of a cell-cycle mutant of Chinese hamster ovary cells. (1977) (3)
Reversible structural changes in the influenza hemagglutinin precursor at membrane fusion pH (2022) (3)
The Structure of the Small Polypeptide Chain of the Hemagglutinin of an Asian Influenza Virus Japan 305/57 — Bellamy/42 (H2N1) (1978) (3)
Immune recognition of influenza virus haemagglutinin. (1989) (2)
SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects (2020) (2)
Crystallization and preliminary X‐ray diffraction studies of the influenza C virus glycoprotein (1996) (2)
Protozoal replication: effects on the host cell. (1980) (2)
Antigenic Variation in Influenza Virus Hemagglutinins (2018) (2)
Studies on the Structure of the Hemagglutinin (1978) (2)
The refinement of the haemagglutinin membrane glycoprotein of influenza virus. Addendum (1987) (1)
Aspects of the Fusogenic Activity of Influenza Hemagglutinin Peptides by Molecular Dynamics Simulations (2005) (1)
Chapter 20 Viral membranes (1998) (1)
The structure and role of the carbohydrate moieties of influenza virus haemagglutinin. (1983) (1)
Influenza A virus enhances IgE-mediated histamine release from human basophil leukocytes. Examination of the effect of viral neuraminidase and haemagglutinin (1989) (1)
Cryocrystallography of influenza virus hemagglutinin crystals. (1995) (1)
Correction for Basner et al., Mars 520-d mission simulation reveals protracted crew hypokinesis and alterations of sleep duration and timing (2013) (1)
Hemagglutinin Traits Determine Transmission of Avian A/H10N7 Virus between Mammals (2020) (1)
Genetics of Influenza Viruses (1983) (1)
REVIEW ARTICLE Influenza Virus Transcription (1978) (1)
Structure of the Neuraminidase from the B/Lyon/CHU/15.216/2011 virus (2014) (0)
Structure of the A_Equine_Richmond_07 H3 haemagglutinin in complex with Sialyl Lewis X (2014) (0)
FRS 1981 20 February 2004 : Elected − − Fred Brown . 31 January 1925 (2007) (0)
Crystal structure of the haemagglutinin mutant (Gln226Leu, Del228) from an H10N7 seal influenza virus isolated in Germany in complex with human receptor analogue 6'-SLN (2020) (0)
Crystal structure of the haemagglutinin from a H10N7 seal influenza virus isolated in Germany in complex with human receptor analogue, 6'-SLN (2020) (0)
Structure of the A_Equine_Newmarket_2_93 H3 haemagglutinin (2014) (0)
Structural studies of influenza virus neutralization by antibodies (2000) (0)
Helio Gelli Pereira. 23 September 1918 — 16 August 1994 (1999) (0)
Crystal structure of the haemagglutinin mutant (Gln226Leu, Del228) from an H10N7 seal influenza virus isolated in Germany (2020) (0)
Structure of the A_mallard_Sweden_51_2002 H10 Avian Haemmaglutinin (2014) (0)
Human H7N9 Influenza Virus Haemagglutinin (with Asn-133 Glycosylation) in Complex with Avian Receptor Analogue 3'-SLN (2013) (0)
Crystal Structure of the Haemagglutinin from a Transmissible Mutant H5 Influenza Virus (2013) (0)
N8 neuraminidase in complex with peramivir (2006) (0)
INFLUENZA VIRUS (VN1194) H5 E190D mutant HA with LSTa (2013) (0)
Coiled Coils in Both Intracellular Minireview Vesicle and Viral Membrane Fusion (1998) (0)
Structure of the A_mallard_Sweden_51_2002 H10 Avian Haemmaglutinin in complex with avian receptor analog Su-3SLN (2014) (0)
structure of H2 avian jena hemagglutinin with human receptor (2009) (0)
Table of Contents (1990) (0)
1930 Swine H1 Hemagglutinin (2004) (0)
CRYSTAL STRUCTURE OF H9 HAEMAGGLUTININ BOUND TO LSTC RECEPTOR ANALOG (2001) (0)
structure of influenza H2 duck Ontario hemagglutinin (2009) (0)
Crystal structure of the haemagglutinin mutant (Gln226Leu) from an H10N7 seal influenza virus isolated in Germany in complex with avian receptor analogue 3'-SLN (2020) (0)
Structure of MEDI8852 Fab Fragment in Complex with H7 HA (2016) (0)
Crystal structure of haemagglutinin from (A/seal/Germany/1/2014) seal H10N7 influenza virus (2020) (0)
the structure of influenza H2 human singapore hemagglutinin (2009) (0)
Crystal structure of the haemagglutinin mutant (Gln226Leu, Del228) from an H10N7 seal influenza virus isolated in Germany in complex with avian receptor analogue 3'-SLN (2020) (0)
Structure of the A_Equine_Richmond_07 H3 haemagglutinin (2014) (0)
INFLUENZA VIRUS (VN1194) H5 HA A138V mutant with LSTa (2013) (0)
Crystal structure of the haemagglutinin from a transmissible H10N7 seal influenza virus isolated in Netherland in complex with avian receptor analogue, 3'-SLN (2020) (0)
Haemagglutinin of 2005 Human H3N2 Virus (2012) (0)
Crystal structure of H8 haemagglutinin (2020) (0)
Haemagglutinin of H10N8 Influenza Virus Isolated from Humans in Complex with Human Receptor Analogue 6'SLN (2014) (0)
Crystal structure of the haemagglutinin mutant (Gln226Leu, Gly228Ser) from an H10N7 seal influenza virus isolated in Germany in complex with human receptor analogue 6'-SLN (2020) (0)
structure of H2 japan hemagglutinin (2009) (0)
Structures of influenza H2 Hemagglutinins (2009) (0)
Crystal Structure of H5 (VN1194) Asn186Lys/Gly143Arg Mutant Haemagglutinin (2014) (0)
Structure of influenza A neutralizing antibody selected from cultures of single human plasma cells in complex with human H3 Influenza haemagglutinin. (2011) (0)
structure of H1 duck albert hemagglutinin with human receptor (2009) (0)
Avian Influenza H 5 N 1 Viruses Broadly Neutralizes Highly Pathogenic Conserved Epitope of H 5 Hemagglutinin A Human Antibody Recognizing a (2012) (0)
H5 Haemagglutinin in Complex with Sialyl-Lewis X (2013) (0)
Fred Brown. 31 January 1925 — 20 February 2004 (2007) (0)
INFLUENZA VIRUS HEMAGGLUTININ (1998) (0)
The Membrane Fusion Activity of the Influenza Virus Haemagglutinin Glycoprotein (1985) (0)
Crystal Structure of the Haemagglutinin (with Asn-133 Glycosylation) from an H7N9 Influenza Virus Isolated from Humans (2013) (0)
Haemagglutinin of 2004 Human H3N2 Virus (2012) (0)
H5 (VN1194) Asn186Lys Mutant Haemagglutinin in Complex with Avian Receptor Analogue 3'SLN (2014) (0)
H5 Haemagglutinin in Complex with 6-O-Sulfo-Sialyl-Lewis X (Sulfated Lewis X) (2013) (0)
N8 neuraminidase in complex with oseltamivir (2006) (0)
N8 neuraminidase in complex with DANA (2006) (0)
Correction (1965) (0)
Crystal structure of the haemagglutinin from a transmissible H10N7 seal influenza virus isolated in Netherland (2020) (0)
THE STRUCTURE AND FUNCTION OF TIlE HEMAGGLUTININ MEMBRANE GLYCOPROTEIN OF INFL1JENZA VIRUS (1987) (0)
Intracellular transport ofsoluble andmembrane-bound glycoproteins: folding, assembly andsecretion of anchor-free influenza hemagglutinin (1990) (0)
Crystal structure of the haemagglutinin mutant (Gln226Leu, Gly228Ser) from an H10N7 seal influenza virus isolated in Germany (2020) (0)
Structure of the A_Canine_Colorado_17864_06 H3 haemagglutinin in complex with 6SO4-3SLN (2014) (0)
N1 Neuraminidase H274Y + Zanamivir (2008) (0)
N1 neuraminidase in complex with oseltamivir 2 (2006) (0)
N1 neuraminidase in complex with oseltamivir 1 (2006) (0)
Steroid hormonesynthesis bya vaccinia enzyme: a new typeofvirus virulence factor (1992) (0)
Structureof the haemagglutinin-esterase-fusionglycoproteinof influenzaCvirus (0)
Crystal Structure of H5 (tyTy) Influenza Virus Haemagglutinin (2013) (0)
structure of influenza H2 avian hemagglutinin with avian receptor (2009) (0)
Crystal structure of H5 (tyTy) Del133/Ile155Thr Mutant Haemagglutinin (2014) (0)
STRUCTURE OF AVIAN H5 HAEMAGGLUTININ BOUND TO LSTC RECEPTOR ANALOG (2001) (0)
structure of H2 japan hemagglutinin with human receptor (2009) (0)
The Ribonucleic Acids (1973) (0)
M. Joseph (Jo) Colston (1948–2003) (2003) (0)
Crystal Structure of H5 (VN1194) Influenza Haemagglutinin (2013) (0)
Sequential receptor binding primes the SARS-CoV-2 S glycoprotein for membrane fusion (2020) (0)
Studies of the Hong Kong Influenza Hemagglutinin (1985) (0)
structure of H1 1918 hemagglutinin with human receptor (2009) (0)
Structure of the A_Equine_Newmarket_2_93 H3 haemagglutinin in complex with 6SO4-Sialyl Lewis X (2014) (0)
Structure of the A_Equine_Richmond_07 H3 haemagglutinin in complex with 3SLN (2014) (0)
1930 H1 Hemagglutinin in complex with LSTC (2004) (0)
Studies on the Structure and Activities of Influenza Virus Haemagglutinin (1984) (0)
Crystal structure of H12 Haemagglutinin (2020) (0)
Structure of MEDI8852 Fab Fragment (2016) (0)
H1 haemagglutinin receptor complexes (2004) (0)
Influenza hemagglutinin structure and antigenicity (2005) (0)
Protein Reviews Volume 1 : Viral MembraneProteins: Structure, Function, and Drug Design (2005) (0)
5 Aspects of the Fusogenic Activity of Influenza Hemagglutinin Peptides by Molecular Dynamics Simulations (0)
Cellular Events Preceding Interferon Formation (2008) (0)
H1 Haemagglutinin Receptor Binding (2006) (0)
N8 neuraminidase in open complex with oseltamivir (2006) (0)
Structure of the A_Canine_Colorado_17864_06 H3 haemagglutinin (2014) (0)
Crystal structure of the haemagglutinin mutant (Gln226Leu) from an H10N7 seal influenza virus isolated in Germany (2020) (0)
structure of influenza H2 hemagglutinin with human receptor (2009) (0)
Crystal Structure of H5 (VN1194) Ser227Asn/Gln196Arg Mutant Haemagglutinin (2014) (0)
N4 neuraminidase in complex with DANA (2006) (0)
23662 Ligand Recognition by Influenza Virus (2001) (0)
Variation in influenza viruses (2006) (0)
Structural transitions in influenza haemagglutinin at membrane fusion pH (2020) (0)
H5 Haemagglutinin in Complex with 6-O-Sulfo-2,3-Sialyllactosamine (Sulfated 3'SLN) (2013) (0)
Lipid Bilayer Rigidity Affects the Fusion Kinetics of Individually Observed Influenza Particles (2010) (0)
Haemagglutinin of 1968 Human H3N2 Virus in Complex with Human Receptor Analogue LSTc (2012) (0)
Structure of the A_Canine_Colorado_17864_06 H3 haemagglutinin in complex with 6SO4 Sialyl Lewis X (2014) (0)
Effects of actinomycin D and 2-mercapto-1-(beta-4-pyridethyl) benzimidazole on the incorporation of [3H]uridine by chick embryo cells. (1967) (0)
H5 (VN1194) Ser227Asn/Gln196Arg Mutant Haemagglutinin in Complex with Avian Receptor Analogue 3'SLN (2014) (0)
Structure of the A_Equine_Richmond_07 H3 haemagglutinin mutant Ser30Thr (2014) (0)
1930 Swine H1 Hemagglutinin complexed with LSTA (2004) (0)
H5 (tyTy) Del133/Ile155Thr Mutant Haemagglutinin in Complex with Avian Receptor Analogue 3'SLN (2014) (0)
CRYSTAL STRUCTURE OF EHA2 (23-185) (2000) (0)
CRYSTAL STRUCTURE OF H9 HAEMAGGLUTININ COMPLEXED WITH LSTA RECEPTOR ANALOG (2001) (0)
Antigenicity of the Influenza Haemagglutinin Membrane Glycoprotein (1987) (0)
Changes in the conformation of inf the pH optimum of virus-mediated (virus glycoprotein/lipid binding/detergent binding) (2016) (0)
Cell Binding and Membrane Fusion Activities of Influenza Viruses (1988) (0)
STRUCTURE OF H5 AVIAN HAEMAGGLUTININ (2001) (0)
Structure of the A_Canine_Colorado_17864_06 H3 haemagglutinin Met29Ile mutant (2014) (0)
Structure of MEDI8852 Fab Fragment in Complex with H5 HA (2016) (0)
Targets for the Design of Antiviral Agents: Targets in Orthomyxoviruses (1984) (0)
structure of influenza H2 duck Ontario hemagglutinin with avian receptor (2009) (0)
STRUCTURE OF INFLUENZA A NEUTRALIZING ANTIBODY SELECTED FROM CULTURES OF SINGLE HUMAN PLASMA CELLS IN COMPLEX WITH HUMAN H1 INFLUENZA HAEMAGGLUTININ. (2011) (0)
Cryoerystallography of Influenza Virus Hemagglufinin Crystals (1995) (0)
CRYSTAL STRUCTURE OF SWINE H9 HAEMAGGLUTININ (2001) (0)
Structure of the Neuraminidase from the B/Lyon/CHU/15.216/2011 virus in complex with Oseltamivir (2014) (0)
INFLUENZA VIRUS (VN1194) H5 I155F mutant HA (2013) (0)
Haemagglutinin from a Transmissible Mutant H5 Influenza Virus in Complex with Avian Receptor Analogue 3'-SLN (2013) (0)
Crystal Structure of a Complex formed between FLD194 Fab and Transmissible Mutant H5 Haemagglutinin (2015) (0)
Crystal structure of the haemagglutinin mutant (Gln226Leu, Gly228Ser) from an H10N7 seal influenza virus isolated in Germany in complex with avian receptor analogue 3'-SLN (2020) (0)
Visualizing Viral Fusion At The Single-particle Level (2009) (0)
Influenza virus (VN1194) H5 HA (2006) (0)
H7N3 Avian Influenza Virus Haemagglutinin in Complex with Avian Receptor Analogue 3'-SLN (2013) (0)
Crystal structure of the haemagglutinin from a H10N7 seal influenza virus isolated in Germany in complex with avian receptor analogue, 3'-SLN (2020) (0)
Crystal Structure of H5 (VN1194) Gln196Arg Mutant Haemagglutinin (2014) (0)
Structure of the Neuraminidase from the B/Brisbane/60/2008 virus in complex with Oseltamivir (2014) (0)
INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH AN ANTIBODY THAT PREVENTS THE HEMAGGLUTININ LOW PH FUSOGENIC TRANSITION (2002) (0)
Crystal structure of the haemagglutinin mutant (Gln226Leu) from an H10N7 seal influenza virus isolated in Germany with human receptor analogue, 6'SLN (2020) (0)
Structure of the A_Equine_Newmarket_2_93 H3 haemagglutinin in complex with 6SO4-3SLN (2014) (0)
Structure of the Neuraminidase from the B/Brisbane/60/2008 virus. (2014) (0)
INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY (1996) (0)
STRUCTURE OF AVIAN H5 HAEMAGGLUTININ COMPLEXED WITH LSTA RECEPTRO ANALOG (2001) (0)
Crystal structure of the haemagglutinin mutant (Gln226Leu, Gly228Ser) from an H10N7 seal influenza virus isolated in Germany with 2mM EDTA (2020) (0)
Crystal structure of the haemagglutinin from a transmissible H10N7 seal influenza virus isolated in Netherland in complex with human receptor analogue 6'-SLN (2020) (0)
INFLUENZA VIRUS HEMAGGLUTININ, (ESCAPE) MUTANT WITH THR 131 REPLACED BY ILE, COMPLEXED WITH A NEUTRALIZING ANTIBODY (1998) (0)
the structure of influenza H2 human singapore hemagglutinin with avian receptor (2009) (0)
INFLUENZA VIRUS (VN1194) H5 HA with LSTa (2013) (0)
Crystal Structure of an H7N3 Avian Influenza Virus Haemagglutinin (2013) (0)
BHA of Ukr/63 (2003) (0)
Do the variable surface glycoproteins of parasites have a function? (1984) (0)

This paper list is powered by the following services:

Other Resources About John Skehel

en.wikipedia.org

What Schools Are Affiliated With John Skehel?

John Skehel is affiliated with the following schools:

University of Manchester Institute of Science and Technology
University of Aberdeen
Aberystwyth University
Harvard University